Clinical studies recruiting near Kansas City

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

A Study to Determine the Efficacy and Safety of Finerenone and SGLT2i in Combination in Hospitalized Patients With Heart
Phase 3 · CON-10002 Kansas City, MO Investigative Site · Colorado Prevention Center · NCT06024746 Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)
Phase 3 · Merck Sharp & Dohme LLC · NCT06393374 MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Wi
Phase 2 · University of Kansas Cancer Center · National Cancer Institute (NCI) · NCT05564390 This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in
Phase 3 · Saint Luke's Cancer Institute · Pfizer · NCT06758401 Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed
Phase 3 · Children's Mercy Hospitals and Clinics · National Cancer Institute (NCI) · NCT06172296 A Long-Term Safety Study of Elismetrep (K-304) in the Acute Treatment of Migraine
Phase 3 · AMR Clinical - Kansas City · Kallyope Inc. · NCT07674654 Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small C
Phase 3 · University of Kansas Cancer Center · NRG Oncology · NCT05624996 A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have or Have Not Been Treated With Biologic Medicines
Phase 3 · AARR- Kansas City Physician Partners · Takeda · NCT06671496 Testing the Addition of Anti-Cancer Drug Sonrotoclax, to the Standard Treatment Zanubrutinib, for Previously Untreated C
Phase 3 · University of Kansas Cancer Center · Alliance for Clinical Trials in Oncology · NCT07321652 Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiov
Phase 3 · Alliance for Multispecialty Research - Kansas City · Amgen · NCT07037433 Testing the Addition of a New Anti-cancer Drug, M3814 (Peposertib), to the Usual Radiotherapy in Patients With Locally A
Phase 1/Phase 2 · University of Kansas Cancer Center · National Cancer Institute (NCI) · NCT04172532 A Study to Assess the Dose, Adverse Events, and Change in Disease Activity of Livmoniplimab as an Intravenous (IV) Solut
Phase 2/Phase 3 · AbbVie · NCT06109272 Testing the Addition of an Anti-Cancer Drug, Triapine, to the Usual Radiation Therapy for Recurrent Glioblastoma or Astr
Phase 1 · University of Kansas Cancer Center · National Cancer Institute (NCI) · NCT06860594 Testing an Enhanced Digital Delivery Model for Inherited Cancer Genetic Testing in Young Adults With Cancer
NA · Alliance for Clinical Trials in Oncology · NCT07091617 A Clinical Trial to Evaluate Efficacy and Safety of Xeomin® Injections for Preventing Episodic Migraine
Phase 3 · Merz Therapeutics GmbH · NCT07018700 A Study to Learn More About How Safe Finerenone is, When it is Taken for a Longer Time With Standard Treatment, in Child
Phase 3 · Children's Mercy Hospital Kansas City - Cardiology · Bayer · NCT07192952 Study of AMG 509 in Participants With Metastatic Castration-Resistant Prostate Cancer
Phase 1 · Amgen · NCT04221542 A Study to Understand How the Study Medicine (PF-06823859) Works in People With Active Idiopathic Inflammatory Myopathie
Phase 3 · KU Clinical Research Center - Clinical and Translational Sci · Pfizer · NCT05895786 Hydrogen's Feasibility and Safety as a Therapy in ECPR
Phase 1 · Children's Mercy Kansas City · Boston Children's Hospital · NCT05574296 First-in-Human Study of VNT-101: Safety, Tolerability, and Pharmacokinetics
Phase 1 · National Institute of Allergy and Infectious Diseases (NIAID · NCT07169318 Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
Phase 3 · University of Kansas Cancer Center · NRG Oncology · NCT05946213 PRESERVE: LUPKYNIS in Combination With Belimumab, Obinutuzumab or Anifrolumab in Patients With Lupus Nephritis
Phase 4 · Kansas City Physician Partners · Aurinia Pharmaceuticals Inc. · NCT07611214 EASi-KIDNEY™ (The Studies of Heart & Kidney Protection With BI 690517 in Combination With Empagliflozin)
Phase 3 · University of Kansas Medical Center · Boehringer Ingelheim · NCT06531824 Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patient
Phase 2 · University of Kansas Cancer Center · NRG Oncology · NCT06532279 A Study Comparing Tarlatamab, Durvalumab, Carboplatin, and Etoposide Versus Durvalumab, Carboplatin, and Etoposide in Fi
Phase 3 · Amgen · NCT07005128 Extension Study to Evaluate Safety and Tolerability of Oral Dersimelagon (MT-7117) in Subjects With Erythropoietic Proto
Phase 3 · Kansas City Research Institute · Tanabe Pharma America, Inc. · NCT05005975 A Study to Find Out if BI 764198 Helps Adults and Adolescents With a Kidney Condition Called Focal Segmental Glomerulosc
Phase 3 · Providence Medical Center · Boehringer Ingelheim · NCT07220083 Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
Phase 2/Phase 3 · Saint Luke's Hospital of Kansas City · NRG Oncology · NCT05174169 SAFety and Efficacy of Human Anti-thymocyte ImmunoGlobUlin SAB-142 ARresting Progression of Type 1 Diabetes
Phase 2 · Children's Mercy Hospital Kansas City - Pediatric Care Clini · SAb Biotherapeutics, Inc. · NCT07187531 Conquer-AF Protocol for Redo Ablation Procedures in Recurrent Paroxysmal and Persistent Atrial Fibrillation Using the Sp
NA · Kansas City Heart Rhythm Institute (Midwest Heart and Vascul · Medtronic Cardiac Ablation Solutions · NCT07298473

Look up another city

Look up another condition